[Explanation] On August 13, Li Jingzhong, director of the Tibet Autonomous Region Centers for Disease Control and Prevention, introduced the latest situation in Tibet in terms of the characteristics of the current round of the new coronavirus, epidemic prevention and control, and drug reserves in an online interview with reporters.
[Concurrent] Li Jingzhong, director of the Tibet Autonomous Region Center for Disease Control and Prevention
We summarize the current epidemic situation in the whole region, then we can feel that it is now clearly showing a trend of spreading in many places in the whole region and spreading on a large scale. The occurrence of multiple clustered outbreaks.
We believe that the epidemic is still in a stage of rapid rise.
[Explanation] Li Jingzhong introduced that through the whole gene sequencing of some virus strains, the strain type of this Tibet epidemic is mainly the new coronavirus variant strain Omicron BA.2.76, which is a family clustered disease, which is imported and has a relatively high incidence. Strong contagion.
[Concurrent] Li Jingzhong, director of the Tibet Autonomous Region Center for Disease Control and Prevention
The case of the new coronary pneumonia caused by the BA.2.76 strain is still based on this recessive infection, that is to say (yes) what we usually call asymptomatic infections, with relatively mild symptoms, but with strong symptoms. of this spreading ability.
[Explanation] Since the outbreak of the epidemic, on the basis of precise prevention and control, Tibet has implemented a two-pronged approach to epidemic control and investigation to reduce the spread and overflow of the epidemic.
[Concurrent] Li Jingzhong, director of the Tibet Autonomous Region Center for Disease Control and Prevention
As long as there is a risk, as long as there is a risk of the spread of the epidemic, regional screening work will continue to be carried out according to different scopes and different purposes.
[Explanation] Li Jingzhong introduced that at present, drugs used in virus treatment are also making continuous progress.
[Concurrent] Li Jingzhong, director of the Tibet Autonomous Region Center for Disease Control and Prevention
Before the epidemic began, our Tibet Autonomous Region had a specific drug for this new coronary pneumonia. In fact, we made a certain reserve, which is still very sufficient.
Again, whether it is from drugs or from the ability of this medical institution, it should be said that sufficient preparations have been made to deal with the treatment.
[Explanation] It is reported that the makeshift hospitals in Lhasa, Shigatse, Qamdo and other places in Tibet have been put into use one after another, and are playing an active role in the prevention and control of the epidemic.
[Concurrent] Li Jingzhong, director of the Tibet Autonomous Region Center for Disease Control and Prevention
The construction of Fangcang shelter hospitals is a very important part of our measures to support this treatment system. In order to increase our resource cost for the treatment of asymptomatic infected persons and mild cases, we are now developing this Fangcang shelter hospital in an orderly manner. construction and use.
In fact, before this, some of our key cities have completed the construction of makeshift hospitals, and they have all been put into use one after another.
[Explanation] Li Jingzhong believes that prevention of spread and spillover is the focus of epidemic prevention and control.
After the outbreak of the epidemic, Tibet immediately took various measures, such as dividing risk areas in a timely manner and organizing nucleic acid testing for all employees in some cities.
He said that due to individual reasons, the infectious virus will not be detected until the first or multiple nucleic acid tests, so Tibet will do its best to control the spill.
Reporter Gongsang Ram reported from Lhasa, Tibet
Responsible editor: [Luo Pan]